Alopecia areata: vizsgálatok itt: Lengyelország
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 3. fázisFut, nem toborozA Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- Where
- Bialystok, Bydgoszcz, Gdansk, Katowice, Kielce, Krakow, Lodz, Ostrowiec Świętokrzyski, Rzeszów, Szczecin, Warsaw, Warszawa, Wroclaw
- Életkor
- 6 év to 17 év
- People
- 595 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05723198 · EU 2022-502700-78-00 - 2. fázisTaking peopleA Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
- Where
- Cracow, Gdansk, Ostrowiec Świętokrzyski, Wroclaw
- Életkor
- 18 év to 60 év
- People
- 65 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07533006 · EU 2025-524727-41-00 - 3. fázisNot yet taking people in LengyelországA study in young people and adults to learn about the medicine ritlecitinib for treatment of patchy hair loss, known by the medical term as moderate alopecia areata
- Where
- Gdansk, Katowice, Kraków, Lublin, Nowa Sol, Sosnowiec, Szczecin, Warsaw
- People
- 90 worldwide
- Run by
- Pfizer Inc.
See details and how to join2026-526355-62-00 - 3. fázisFut, nem toborozA Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Where
- Gdansk, Katowice, Krakow, Lublin, Nowa Sol, Poznan, Sosnowiec, Szczecin, Warsaw, Warszawa, Wroclaw, Wrocław
- Életkor
- 12 év and over
- People
- 674 worldwide
- Run by
- Pfizer
See details and how to joinNCT06873945 · EU 2024-519370-40-00 - 3. fázisFut, nem toborozA Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Where
- Bialystok, Cracow, Elblag, Gdansk, Katowice, Krakow, Torun, Warsaw
- Életkor
- 12 év to 63 év
- People
- 1500 worldwide
- Run by
- AbbVie
See details and how to joinNCT06012240 · EU 2023-505061-82-01 - 3. fázisTaking peopleA Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
- Where
- Bialystok, Katowice, Krakow, Łódź, Lublin, Ozarowice, Rzeszów, Warsaw, Warszawa, Wroclaw
- Életkor
- 6 év to 14 év
- People
- 140 worldwide
- Run by
- Pfizer
See details and how to joinNCT07029828 · EU 2024-515439-31-00 - 2. fázisTaking peopleA Study of LAD603 in Adults With Alopecia Areata
- Where
- Katowice, Kielce, Krakow, Nowa Sol, Torun, Warsaw, Wroclaw
- Életkor
- 18 év to 65 év
- People
- 136 worldwide
- Run by
- Almirall, S.A.
See details and how to joinNCT07311564 · EU 2025-523342-27-00